Cargando…

COPD symptom burden: impact on health care resource utilization, and work and activity impairment

BACKGROUND: Chronic obstructive pulmonary disease (COPD) can greatly impact the quality of life by limiting patients’ activities. However, data on impact of symptomatic burden on the health care resource utilization (HCRU) and employment in COPD are lacking. We examined the association between COPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Bo, Small, Mark, Bergström, Gina, Holmgren, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327905/
https://www.ncbi.nlm.nih.gov/pubmed/28260874
http://dx.doi.org/10.2147/COPD.S123896
_version_ 1782510818083995648
author Ding, Bo
Small, Mark
Bergström, Gina
Holmgren, Ulf
author_facet Ding, Bo
Small, Mark
Bergström, Gina
Holmgren, Ulf
author_sort Ding, Bo
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) can greatly impact the quality of life by limiting patients’ activities. However, data on impact of symptomatic burden on the health care resource utilization (HCRU) and employment in COPD are lacking. We examined the association between COPD Assessment Test (CAT) score and direct/indirect costs associated with HCRU and work productivity. METHODS: Data from >2,100 patients with COPD consulting for routine care were derived from respiratory disease-specific programs in Europe, the USA and China. Questionnaires, including CAT and Work Productivity and Activity Impairment (WPAI), were used to collect the past and current disease status data and HCRU characteristics from physicians (general practitioners/specialists) and patients. A regression approach was used to quantify the association of CAT with HCRU and WPAI variables. CAT score was modeled as a continuous independent variable (range: 0–40). RESULTS: Ninety percent of patients with COPD had a CAT score ≥10. Short-acting therapy and maintenance bronchodilator monotherapy, respectively, were currently prescribed to patients with CAT scores of 10–19 (5.8% and 27.6%), 20–29 (5.1% and 13.1%) and 30–40 (2.8% and 6.6%). Prescribing of maintenance bronchodilator dual therapy was low across the CAT score groups (0–9, 7.8%; 10–19, 6.4%; 20–29, 5.9%; 30–40, 4.4%), whereas maintenance triple combination therapy was prescribed more commonly in patients with higher CAT scores (0–9, 16.1%; 10–19, 23.2%; 20–29, 25.9%; 30–40, 35.5%). Increasing CAT scores were significantly associated with a higher frequency of primary care physician visits (P<0.001), pulmonologist visits (P=0.007), exacerbations requiring hospitalization (P<0.001) and WPAI scores (P<0.001). CONCLUSION: Most patients with COPD presented with high symptom levels, despite being treated for COPD. Increasing symptom burden was associated with increasing HCRU and had a detrimental impact on work productivity.
format Online
Article
Text
id pubmed-5327905
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53279052017-03-03 COPD symptom burden: impact on health care resource utilization, and work and activity impairment Ding, Bo Small, Mark Bergström, Gina Holmgren, Ulf Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) can greatly impact the quality of life by limiting patients’ activities. However, data on impact of symptomatic burden on the health care resource utilization (HCRU) and employment in COPD are lacking. We examined the association between COPD Assessment Test (CAT) score and direct/indirect costs associated with HCRU and work productivity. METHODS: Data from >2,100 patients with COPD consulting for routine care were derived from respiratory disease-specific programs in Europe, the USA and China. Questionnaires, including CAT and Work Productivity and Activity Impairment (WPAI), were used to collect the past and current disease status data and HCRU characteristics from physicians (general practitioners/specialists) and patients. A regression approach was used to quantify the association of CAT with HCRU and WPAI variables. CAT score was modeled as a continuous independent variable (range: 0–40). RESULTS: Ninety percent of patients with COPD had a CAT score ≥10. Short-acting therapy and maintenance bronchodilator monotherapy, respectively, were currently prescribed to patients with CAT scores of 10–19 (5.8% and 27.6%), 20–29 (5.1% and 13.1%) and 30–40 (2.8% and 6.6%). Prescribing of maintenance bronchodilator dual therapy was low across the CAT score groups (0–9, 7.8%; 10–19, 6.4%; 20–29, 5.9%; 30–40, 4.4%), whereas maintenance triple combination therapy was prescribed more commonly in patients with higher CAT scores (0–9, 16.1%; 10–19, 23.2%; 20–29, 25.9%; 30–40, 35.5%). Increasing CAT scores were significantly associated with a higher frequency of primary care physician visits (P<0.001), pulmonologist visits (P=0.007), exacerbations requiring hospitalization (P<0.001) and WPAI scores (P<0.001). CONCLUSION: Most patients with COPD presented with high symptom levels, despite being treated for COPD. Increasing symptom burden was associated with increasing HCRU and had a detrimental impact on work productivity. Dove Medical Press 2017-02-21 /pmc/articles/PMC5327905/ /pubmed/28260874 http://dx.doi.org/10.2147/COPD.S123896 Text en © 2017 Ding et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ding, Bo
Small, Mark
Bergström, Gina
Holmgren, Ulf
COPD symptom burden: impact on health care resource utilization, and work and activity impairment
title COPD symptom burden: impact on health care resource utilization, and work and activity impairment
title_full COPD symptom burden: impact on health care resource utilization, and work and activity impairment
title_fullStr COPD symptom burden: impact on health care resource utilization, and work and activity impairment
title_full_unstemmed COPD symptom burden: impact on health care resource utilization, and work and activity impairment
title_short COPD symptom burden: impact on health care resource utilization, and work and activity impairment
title_sort copd symptom burden: impact on health care resource utilization, and work and activity impairment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327905/
https://www.ncbi.nlm.nih.gov/pubmed/28260874
http://dx.doi.org/10.2147/COPD.S123896
work_keys_str_mv AT dingbo copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment
AT smallmark copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment
AT bergstromgina copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment
AT holmgrenulf copdsymptomburdenimpactonhealthcareresourceutilizationandworkandactivityimpairment